Autres langues PTC Therapeutics, Inc.

Actions

Temps réel estimé Cboe BZX Autres places de cotation 16:04:42 20/05/2024			Varia. 5j.	Varia. 1 janv.
40,03 ^USD	+20,95 %		+25,02 %	+43,80 %

15:14	Mise à jour sectorielle : Les actions du secteur de la santé mitigées avant la cloche lundi	MT
15:01	Mise à jour sectorielle : Soins de santé	MT

Sector Update: Health Care Stocks Mixed Pre-Bell Monday	15:14
Sector Update: Health Care	15:01
PTC Therapeutics Says European Commission Seeking Review of Negative Opinion on Translarna	14:46
PTC Therapeutics Announces European Commission Returns Translarna™ Opinion to CHMP For Re-evaluation	13:01
Sector Update: Health Care Stocks Steady Premarket Tuesday	14/05
Sector Update: Health Care	14/05
PTC Therapeutics Gets FDA Priority Review for Upstaza Biologics License Application	14/05
PTC Therapeutics Gets FDA Priority Review of Upstaza Gene Therapy	14/05
PTC Therapeutics Announces FDA Acceptance and Priority Review of the BLA for Upstaza™	14/05
PTC Therapeutics Announces FDA Acceptance and Priority Review of the BLA for Upstaza	14/05
PTC Therapeutics : Corporate Presentation – May 2024	04/05
PTC Therapeutics to Participate at Upcoming Investor Conferences	02/05
North American Morning Briefing : More Earnings -2-	30/04
Sector Update: Health Care Stocks Edge Higher Late Afternoon	26/04
Sector Update: Health Care	26/04
PTC Therapeutics Shares Rise After Better-Than-Expected Q1 Results	26/04
PTC Therapeutics : Q1 2024 FLS	25/04
PTC Therapeutics: Q1 Earnings Snapshot	25/04
Earnings Flash (PTCT) PTC THERAPEUTICS Posts Q1 Revenue $210.1M, vs. Street Est of $163.8M	25/04
PTC Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04

Aucun résultat pour cette recherche